A shuttered AstraZeneca research center in Montreal has reemerged as Neomed, a public-private partnership between AstraZeneca, Pfizer and the government of Quebec. The institute will continue to develop AstraZeneca's pain compounds and plans to grow its pipeline with regional partnerships.